Strategic Partnership
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
Hovione
PR-M03-23-06Mar 22, 2023
CDMO Leadership Award
Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise
Hovione
PR-M03-23-01Mar 08, 2023
Continuous Tableting
Hovione and GEA Announce a Strategic Collaboration to Advance Continuous Tableting
Hovione
PR-M12-22-02-176Dec 14, 2022
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04May 09, 2022
Business Leadership
Jean-Luc Herbeaux to Become Hovione CEO
Hovione
PR-M02-22-23Feb 25, 2022
Strategic Partnership
Hovione and Zerion Pharma Announce a Strategic Partnership to Market the Dispersome® Technology Platform
Hovione
PR-M02-22-19Feb 22, 2022
Strategic Collaboration
Hovione and iBET Announce Strategic Collaboration
Hovione
PR-M05-21-020May 27, 2021
Ophthalmology
Hovione Completes its Phase II Clinical Trial of the First Minocycline Ophthalmic Showing Promise in Dry Eye Disease Associated with Inflamed Meibomian Gland Dysfunction
Hovione
PR-M03-21-003Mar 17, 2021
Screening Service
Hovione Launches ASD-HIPROS the Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation
Hovione
PR-M11-20-033Jan 12, 2021
COVID-19
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury for COVID-19
Hovione
PR-M09-20-26Sep 23, 2020
Drug Development
Bilim Pharmaceuticals, H&T Presspart and Hovione Technology Unveil Collaboration for New Asthma Product: Ventofor Combi Fix Delivered by PowdAir Plus
Hovione Technology
PR-M09-20-NI-02Sep 01, 2020
Leadership
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Hovione
PR-M05-20-NI-006May 04, 2020
Phase II
Hovione Announces Successful End-of-Phase 2 Meeting with the FDA and Outlines Phase 3 Program for Minocycline Topical Gel
Hovione
PR-M09-19-NI-047Sep 20, 2019
Collaboration
Hovione Technology Signs Collaboration Agreement with Kiel University
Hovione Technology
PR-M09-19-NI-012Sep 05, 2019
Formulation
Developing and Characterizing DPI Formulations for Biologics
Eunice Costa; Constança Cacela
Hovione
PAP-Q1-2019-CL-002Apr 12, 2019
Finance
Hovione Issues $50 Million Bond
Hovione
PR-M01-19-NI-081Jan 28, 2019
Formulation
The Coming of Age of Amorphous Solid Dispersions
Márcio Temtem, Ph.D.
Hovione
PAP-Q4-18-CL-004Oct 26, 2018
Expanded Capacity
Hovione Reports on Recent Capacity Expansion and Future Plans to Support Growth
Hovione
PR-M03-18-NI-081Mar 22, 2018
Regulatory
Compliance at Hovione, Annual Inspection Review
Hovione
PR-M03-18-NI-037Mar 12, 2018
Inhalation
Hovione strengthens Inhalation Services portfolio
Hovione
PR-M01-18-NI-084Jan 24, 2018